| scholarly article | Q13442814 |
| P50 | author | Shinya Yamanaka | Q80917 |
| Keisuke Okita | Q73389625 | ||
| Koji Eto | Q87047082 | ||
| Shinji Hirata | Q114555975 | ||
| Kiyosumi Ochi | Q114555977 | ||
| P2093 | author name string | Hiromitsu Nakauchi | |
| Takeaki Dohda | |||
| Naoya Takayama | |||
| Satoshi Nishimura | |||
| Akira Watanabe | |||
| Ken-ichi Fujita | |||
| Akira Sawaguchi | |||
| Nobuyasu Takahashi | |||
| Sou Nakamura | |||
| Hiroshi Endo | |||
| Hideya Seo | |||
| Ken-ichi Harimoto | |||
| Tomo Koike | |||
| P2860 | cites work | Induction of pluripotent stem cells from adult human fibroblasts by defined factors | Q27860967 |
| Generation and rescue of a murine model of platelet dysfunction: the Bernard-Soulier syndrome | Q28509360 | ||
| Caspases and mitochondria in c-Myc-induced apoptosis: identification of ATM as a new target of caspases | Q28581404 | ||
| The WAVE2/Abi1 complex differentially regulates megakaryocyte development and spreading: implications for platelet biogenesis and spreading machinery | Q28589476 | ||
| Metalloproteinase regulation improves in vitro generation of efficacious platelets from mouse embryonic stem cells | Q30483213 | ||
| Lnk regulates integrin alphaIIbbeta3 outside-in signaling in mouse platelets, leading to stabilization of thrombus development in vivo | Q30492556 | ||
| Infusion of mature megakaryocytes into mice yields functional platelets | Q30497158 | ||
| In vivo imaging visualizes discoid platelet aggregations without endothelium disruption and implicates contribution of inflammatory cytokine and integrin signaling | Q30514057 | ||
| A systems-biology analysis of isogenic megakaryocytic and granulocytic cultures identifies new molecular components of megakaryocytic apoptosis | Q33303491 | ||
| BclxL overexpression in megakaryocytes leads to impaired platelet fragmentation | Q33343732 | ||
| Metalloproteinase inhibitors improve the recovery and hemostatic function of in vitro-aged or -injured mouse platelets | Q33349386 | ||
| The biogenesis of platelets from megakaryocyte proplatelets | Q33369405 | ||
| Transient activation of c-MYC expression is critical for efficient platelet generation from human induced pluripotent stem cells | Q33392928 | ||
| Megakaryocytes possess a functional intrinsic apoptosis pathway that must be restrained to survive and produce platelets | Q33397149 | ||
| Congenital amegakaryocytic thrombocytopenia iPS cells exhibit defective MPL-mediated signaling | Q33409483 | ||
| Platelets generated from human embryonic stem cells are functional in vitro and in the microcirculation of living mice | Q33789872 | ||
| Direct recruitment of polycomb repressive complex 1 to chromatin by core binding transcription factors. | Q34030648 | ||
| Characterization of stage progression in chronic myeloid leukemia by DNA microarray with purified hematopoietic stem cells | Q34108458 | ||
| An efficient nonviral method to generate integration-free human-induced pluripotent stem cells from cord blood and peripheral blood cells | Q34314350 | ||
| Immortalization of erythroblasts by c-MYC and BCL-XL enables large-scale erythrocyte production from human pluripotent stem cells | Q34394559 | ||
| Diagnosis and management of refractoriness to platelet transfusion | Q34494961 | ||
| Transcriptional control of the core cell-death machinery | Q35744897 | ||
| Induction of functional platelets from mouse and human fibroblasts by p45NF-E2/Maf | Q36370865 | ||
| Platelet receptor shedding | Q37963244 | ||
| Challenges and promises for the development of donor-independent platelet transfusions | Q38074224 | ||
| c-Myc functionally cooperates with Bax to induce apoptosis | Q39675305 | ||
| Gene expression analysis during platelet-like particle production in phorbol myristate acetate-treated MEG-01 cells | Q39878359 | ||
| Efficient establishment of human embryonic stem cell lines and long-term maintenance with stable karyotype by enzymatic bulk passage | Q40278874 | ||
| Increased megakaryopoiesis in cultures of CD34-enriched cord blood cells maintained at 39 degrees C. | Q40521527 | ||
| Differential impact of Ink4a and Arf on hematopoietic stem cells and their bone marrow microenvironment in Bmi1-deficient mice | Q41779350 | ||
| A rapid, reversible, and tunable method to regulate protein function in living cells using synthetic small molecules | Q42166429 | ||
| Nucleation of platelets with blood-borne pathogens on Kupffer cells precedes other innate immunity and contributes to bacterial clearance | Q42382293 | ||
| Establishment of a human leukaemic cell line (CMK) with megakaryocytic characteristics from a Down's syndrome patient with acute megakaryoblastic leukaemia | Q42814356 | ||
| Clonal analysis unveils self-renewing lineage-restricted progenitors generated directly from hematopoietic stem cells | Q45155046 | ||
| A novel flow cytometry-based platelet aggregation assay. | Q45792585 | ||
| Dynamic Visualization of Thrombopoiesis Within Bone Marrow | Q58450371 | ||
| Role of platelet surface glycoprotein Ibalpha and P-selectin in the clearance of transfused platelet concentrates | Q80596185 | ||
| Generation of functional platelets from human embryonic stem cells in vitro via ES-sacs, VEGF-promoted structures that concentrate hematopoietic progenitors | Q81015137 | ||
| Two differential flows in a bioreactor promoted platelet generation from human pluripotent stem cell-derived megakaryocytes | Q86657049 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Human Induced Pluripotent Stem Cells | Q88981775 |
| P304 | page(s) | 535-548 | |
| P577 | publication date | 2014-02-13 | |
| P1433 | published in | Cell Stem Cell | Q2943975 |
| P1476 | title | Expandable megakaryocyte cell lines enable clinically applicable generation of platelets from human induced pluripotent stem cells | |
| P478 | volume | 14 |
| Q38844338 | 10th anniversary of iPS cells: the challenges that lie ahead |
| Q47610507 | 2017 Military Supplement: Hemoglobin-based Oxygen Carriers: Current State-of-the-Art and Novel Molecules. |
| Q92546005 | A comparison of haematopoietic stem cells from umbilical cord blood and peripheral blood for platelet production in a microfluidic device |
| Q38416517 | A future with less HLA: potential clinical applications of HLA-universal cells |
| Q33433352 | A swine model of acute thrombocytopenia with prolonged bleeding time produced by busulfan |
| Q58751503 | A β1-tubulin-based megakaryocyte maturation reporter system identifies novel drugs that promote platelet production |
| Q26853179 | Advances in cellular technology in the hematology field: What have we learned so far? |
| Q34684558 | An expandable, inducible hemangioblast state regulated by fibroblast growth factor |
| Q91143683 | Application of induced pluripotent stem cells to primary immunodeficiency diseases |
| Q33422077 | BCL-2 is dispensable for thrombopoiesis and platelet survival |
| Q39179984 | Bio-inspired nanomedicine strategies for artificial blood components |
| Q47324534 | Biomaterials and Advanced Technologies for Hemostatic Management of Bleeding. |
| Q33428137 | CRISPR/Cas9-mediated conversion of human platelet alloantigen allotypes |
| Q38391002 | Cell therapy worldwide: an incipient revolution |
| Q35692415 | Comparative analysis of human ex vivo-generated platelets vs megakaryocyte-generated platelets in mice: a cautionary tale |
| Q49557978 | Current status of blood 'pharming': megakaryoctye transfusions as a source of platelets |
| Q52581888 | D-dencichine Regulates Thrombopoiesis by Promoting Megakaryocyte Adhesion, Migration and Proplatelet Formation. |
| Q35533599 | De novo generation of HSCs from somatic and pluripotent stem cell sources |
| Q47296243 | Derivation of Human Induced Pluripotent Stem Cell (iPSC) Lines and Mechanism of Pluripotency: Historical Perspective and Recent Advances |
| Q91629835 | Development of an ex vivo xenogeneic bone environment producing human platelet-like cells |
| Q38877308 | Development of autologous blood cell therapies |
| Q45862868 | Direct lineage reprogramming: a useful addition to the blood cell research toolbox |
| Q33420698 | Efficient generation of megakaryocytes from human induced pluripotent stem cells using food and drug administration-approved pharmacological reagents |
| Q35836174 | Embryonic stem cells as sources of donor-independent platelets |
| Q92219763 | Enabling Large-Scale Ex Vivo Production of Megakaryocytes from CD34+ Cells Using Gas-Permeable Surfaces |
| Q30662306 | Establishment of a sticky, large, oval-shaped thrombocyte cell line from tree frog as an ancestor of mammalian megakaryocytes |
| Q88155044 | Expandable progenitors from induced pluripotent stem cells |
| Q37027646 | From GWAS to function: lessons from blood cells. |
| Q27318499 | Functional comparison of induced pluripotent stem cell- and blood-derived GPIIbIIIa deficient platelets |
| Q37509037 | GSK3β inhibition activates the CDX/HOX pathway and promotes hemogenic endothelial progenitor differentiation from human pluripotent stem cells. |
| Q33432719 | Generation of HLA-universal iPSCs-derived megakaryocytes and platelets for survival under refractoriness conditions |
| Q26771763 | Hematopoietic stem cell expansion and generation: the ways to make a breakthrough |
| Q47382721 | Human NOTCH4 is a key target of RUNX1 in megakaryocytic differentiation |
| Q47879370 | Human adipose tissue-derived stromal cells can differentiate into megakaryocytes and platelets by secreting endogenous thrombopoietin |
| Q110698426 | Human induced pluripotent stem cell-derived platelets loaded with lapatinib effectively target HER2+ breast cancer metastasis to the brain |
| Q36358673 | Identifying and enriching platelet-producing human stem cell-derived megakaryocytes using factor V uptake. |
| Q90489529 | In vitro culture of murine megakaryocytes from fetal liver-derived hematopoietic stem cells |
| Q33443202 | In vitro generation of platelets: Where do we stand? |
| Q97533489 | In vitro platelet production for transfusion purposes: Where are we now? |
| Q47913269 | Induced Pluripotent Stem Cell-Derived Megakaryocytes and Platelets for Disease Modeling and Future Clinical Applications |
| Q48343541 | Induced Pluripotent Stem Cell-Derived Red Blood Cells and Platelet Concentrates: From Bench to Bedside. |
| Q57454780 | Induced Pluripotent Stem Cells and Their Use in Human Models of Disease and Development |
| Q30657328 | Inducible Gata1 suppression expands megakaryocyte-erythroid progenitors from embryonic stem cells |
| Q90733820 | Induction of differentiation of human stem cells ex vivo: Toward large-scale platelet production |
| Q30702462 | Integrated Biophysical and Biochemical Signals Augment Megakaryopoiesis and Thrombopoiesis in a Three-Dimensional Rotary Culture System |
| Q39002353 | Interspecies organogenesis generates autologous functional islets. |
| Q37460935 | Intracranial hemorrhage and platelet transfusion after administration of anti-platelets agents: Fukushima Prefecture |
| Q42639464 | Label free monitoring of megakaryocytic development and proplatelet formation in vitro |
| Q27320898 | Large-scale production of megakaryocytes from human pluripotent stem cells by chemically defined forward programming |
| Q64934930 | Large-scale production of megakaryocytes in microcarrier-supported stirred suspension bioreactors. |
| Q26770863 | Linkage between the mechanisms of thrombocytopenia and thrombopoiesis |
| Q42099250 | Loss of the Arp2/3 complex component ARPC1B causes platelet abnormalities and predisposes to inflammatory disease. |
| Q26801840 | Lost in translation: pluripotent stem cell-derived hematopoiesis |
| Q33424186 | Manipulating megakaryocytes to manufacture platelets ex vivo |
| Q90000806 | Mechanism of platelet α-granule biogenesis: study of cargo transport and the VPS33B-VPS16B complex in a model system |
| Q38777454 | Megakaryocyte Polyploidization and Proplatelet Formation in Low-Attachment Conditions |
| Q64266287 | Megakaryocytes and platelets from a novel human adipose tissue-derived mesenchymal stem cell line |
| Q92256640 | MicroRNA Profiling During Neural Differentiation of Induced Pluripotent Stem Cells |
| Q36119331 | Microfluidic assessment of functional culture-derived platelets in human thrombi under flow |
| Q92570903 | Modeling blood diseases with human induced pluripotent stem cells |
| Q47684382 | Modular flow chamber for engineering bone marrow architecture and function |
| Q33441740 | Mouse RUNX1C regulates premegakaryocytic/erythroid output and maintains survival of megakaryocyte progenitors |
| Q57214406 | Multi-channel silk sponge mimicking bone marrow vascular niche for platelet production |
| Q50077357 | NOTCHing down a win for megakaryocytes |
| Q38495085 | Nanodiagnostics, nanopharmacology and nanotoxicology of platelet-vessel wall interactions. |
| Q89777952 | Novel TPO receptor agonist TA-316 contributes to platelet biogenesis from human iPS cells |
| Q57167167 | On the Way to Platelet Production |
| Q57166306 | On the way to in vitro platelet production |
| Q90577088 | Packaging functionally important plasma proteins into the α-granules of human-induced pluripotent stem cell-derived megakaryocytes |
| Q34209300 | Platelet bioreactor-on-a-chip |
| Q33438649 | Platelet bioreactor: accelerated evolution of design and manufacture |
| Q26743455 | Platelet generation in vivo and in vitro |
| Q40115861 | Platelet production from induced pluripotent stem cells |
| Q38543281 | Platelet-delivered therapeutics |
| Q38333728 | Pluripotent stem cell derived cardiovascular progenitors--a developmental perspective |
| Q35252648 | Programmable 3D silk bone marrow niche for platelet generation ex vivo and modeling of megakaryopoiesis pathologies. |
| Q39076420 | Progress in bio-manufacture of platelets for transfusion |
| Q38977109 | Progress towards generation of human haematopoietic stem cells |
| Q38784723 | Recent developments in ex vivo platelet production. |
| Q93066191 | Recent policies that support clinical application of induced pluripotent stem cell-based regenerative therapies |
| Q34671302 | Road blocks in making platelets for transfusion |
| Q33440176 | Safety and Efficacy of Megakaryocytes Induced from Hematopoietic Stem Cells in Murine and Nonhuman Primate Models |
| Q43010381 | Scalable generation of universal platelets from human induced pluripotent stem cells. |
| Q42247805 | Selective Inhibition of ADAM17 Efficiently Mediates Glycoprotein Ibα Retention During Ex Vivo Generation of Human Induced Pluripotent Stem Cell-Derived Platelets |
| Q42662112 | Separation of in-vitro-derived megakaryocytes and platelets using spinning-membrane filtration |
| Q35087066 | Stem cell therapy. Use of differentiated pluripotent stem cells as replacement therapy for treating disease |
| Q26862370 | Stem cells, megakaryocytes, and platelets |
| Q92881863 | The GABA receptor GABRR1 is expressed on and functional in hematopoietic stem cells and megakaryocyte progenitors |
| Q36675079 | The immunogenicity of platelet-derived FVIII in hemophilia A mice with or without preexisting anti-FVIII immunity |
| Q27321267 | Three-Dimensional Environment Sustains Hematopoietic Stem Cell Differentiation into Platelet-Producing Megakaryocytes |
| Q90285682 | Thrombopoietin knock-in augments platelet generation from human embryonic stem cells |
| Q33442786 | Towards the Manufacture of Megakaryocytes and Platelets for Clinical Application. |
| Q27023005 | Transcription factor-mediated reprogramming toward hematopoietic stem cells |
| Q26770860 | Understanding platelet generation from megakaryocytes: implications for in vitro-derived platelets |
| Q91911682 | Visualization of morphological categories of colonies for monitoring of effect on induced pluripotent stem cell culture status |
| Q92671871 | Von Willebrand Disease: From In Vivo to In Vitro Disease Models |
| Q56362506 | Whirling Platelets Away for Transfusion |
| Q37688424 | iPS cell technologies: significance and applications to CNS regeneration and disease |
| Q92297412 | iPSC-Derived Platelets Depleted of HLA Class I Are Inert to Anti-HLA Class I and Natural Killer Cell Immunity |
Search more.